Trial · NCT01285609
Adverse events730
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 730
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 171 | 475 | |
| other | Anaemia | Blood and lymphatic system disorders | Placebo + Paclitaxel/ Carboplatin | 157 | 473 | |
| other | Decreased appetite | Metabolism and nutrition disorders | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 145 | 475 | |
| other | Decreased appetite | Metabolism and nutrition disorders | Placebo + Paclitaxel/ Carboplatin | 116 | 473 | |
| other | Haemoglobin decreased | Investigations | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 38 | 475 | |
| other | Haemoglobin decreased | Investigations | Placebo + Paclitaxel/ Carboplatin | 30 | 473 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 66 | 475 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Placebo + Paclitaxel/ Carboplatin | 61 | 473 | |
| other | Oedema peripheral | General disorders | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 25 | 475 | |
| other | Oedema peripheral | General disorders | Placebo + Paclitaxel/ Carboplatin | 31 | 473 | |
| other | Peripheral sensory neuropathy | Nervous system disorders | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 71 | 475 | |
| other | Peripheral sensory neuropathy | Nervous system disorders | Placebo + Paclitaxel/ Carboplatin | 98 | 473 | |
| other | White blood cell count decreased | Investigations | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 25 | 475 | |
| other | White blood cell count decreased | Investigations | Placebo + Paclitaxel/ Carboplatin | 31 | 473 | |
| other | Aspartate aminotransferase increased | Investigations | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 34 | 475 | |
| other | Aspartate aminotransferase increased | Investigations | Placebo + Paclitaxel/ Carboplatin | 20 | 473 | |
| other | Asthenia | General disorders | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 80 | 475 | |
| other | Asthenia | General disorders | Placebo + Paclitaxel/ Carboplatin | 55 | 473 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | 10 MG/KG Ipilimumab + Paclitaxel/ Carbop | 32 | 475 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Placebo + Paclitaxel/ Carboplatin | 26 | 473 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01285609/events